Page 2 - Orca Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesAlexandra gomez arteagaScott mcclellanAmerican society of hematologyInternational bloodPresbyterian weill cornell medical centerMarrow transplant researchCellular therapy program at newyorkProduct serviceDrug administrationBio presents promising dataTwo oral presentationsCellular therapy meetingsAmerican societyCellular therapyAssistant professor

Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAlexandra gomez arteagaJoshua murrayKelsey grossmanScott mcclellanAmerican society of hematologyInternational bloodMarrow transplant researchCellular therapy program at newyorkPresbyterian weill cornell medical centerDrug administrationCorporate communicationsOrca bioCellular therapy meetingsAmerican societyCellular therapy

Orca Bio to Present at the 42nd Annual J P Morgan Healthcare Conference

Orca Bio to Present at the 42nd Annual J P Morgan Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Joshua murrayIvan dimovKelsey grossmanCorporate communicationsOrca bioGolden gate room

Orca-Q Showcases Early Efficacy, Acceptable Safety in Haploidentical Stem Cell Transplant Without PTCy

The high-precision cellular product Orca-Q demonstrated early signals of clinical activity as well as an acceptable safety profile for patients undergoing haploidentical stem cell transplantation without posttransplant cyclophosphamide.

United statesStates srourSamera srourDepartment of stem cell transplantationUniversity of texas md anderson cancer centerDivision of cancer medicineStem cell transplantationCancer medicineCancer centerAfrican americanCommon terminology criteriaAdverse eventsOrca bioPalebresib plus ruxolitinibJak inhibitor naive myelofibrosisManifest 2 trial

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatmen

– Orca-T, Orca Bio’s lead investigational high-precision cell therapy, showed similar results in older patients undergoing myeloablative conditioning as seen in younger patients across disease control, non-relapse mortality and overall survival –– Orca-T in older patients given a reduced intensity conditioning regim.

United statesJoshua murraySamer srourIvan dimovKelsey grossmanDepartment of stem cell transplantationDrug administrationCorporate communicationsUniversity of texas md anderson cancer centerAmerican society of hematologyBone marrow transplantation stem cell processing centerOrca bioAmerican societyAnnual meetingOlder patientsCaspian oliai